New Autoimmune Treatments Raise Hope but Demand Rigorous Scrutiny
As revolutionary CAR-T and cell reprogramming therapies emerge for autoimmune diseases, we must critically examine their safety, cost, and long-term impact on American patients and healthcare sovereignty.
By National Security Desk | November 13, 2025